KDA Groupe announces Elixir 420 update

KDA Group Inc. (TSXV: KDA) (“KDA” or the“Corporation”) announces that it proposed to amend the expiry date of 8,000,000 warrants to purchase 8,000,000 Class A Shares of KDA (the “Common shares”) at a price of $0.20 per Common share from November 24, 2021 to November 24, 2022 as permitted under the TSX Venture Exchange (“TSXV”) […]

New bank Financing

Thetford Mines, Quebec – July 20, 2021 – KDA Group Inc. (TSXV: KDA) (“KDA” or the “Corporation”) is pleased to announce it has entered into a commitment letter (the “Commitment Letter”) with Private Debt Partners (“PDP”) regarding terms and conditions of a new term debt financing of up to CAD $7.0 million for a 2-year […]

KDA Groupe – Update

Thetford Mines, Quebec – September 22, 2021 – KDA Group Inc. (TSXV: KDA) (“KDA” or the “Corporation”) is pleased to announce an update on many accomplishments realised during the past few months. Learn more

KDA Group announces KRX updates

Thetford Mines, Quebec – July 7, 2021 – KDA Group Inc. (TSXV: KDA) (“KDA” or the “Corporation”) and its wholly owned subsidiary, Groupe Technologique KDA Inc. (“Tech KDA”) are pleased to announce an update on the KRx dental prescriber platform (the “KRx”). Learn more

KDA Group closes debenture and announces webinar to discuss corporate update

Thetford Mines, Quebec – June 23, 2021 – KDA Group Inc. (TSXV: KDA) (“KDA” or the “Corporation”) is pleased to announce the closing of an unsecured convertible debenture in the amount of $750,000 at a ten percent (10%) interest rate per year for a term of two (2) years (the “Debenture”) with an accredited investor […]

KDA Group announces net earnings for the second quarter of 2021 and an update on its technology projects

Thetford Mines, Quebec – March 23, 2021 – KDA Group Inc. (TSXV: KDA) (“KDA” or the “Corporation”) has released its unaudited condensed consolidated financial results for the second quarter ended January 31, 2021 (“Q2-2021”). The Corporation’s financial results, together with the management’s discussion and analysis, have been filed on SEDAR. All financial figures are in […]

GROUPE TECHNOLOGIQUE KDA SIGNED AN ASSET PURCHASE AGREEMENT WITH ZOOMMED MÉDICAL FOR THE ACQUISITION OF ZRX PRESCRIBER FOR DEVELOPMENT AND EXPLOITATION IN THE UNITED STATES, EUROPE AND UNITED KINGDOM

Thetford Mines, Quebec – March 10, 2021 – KDA Group Inc. (TSXV: KDA) (“KDA” or the “Corporation”) is proud to announce, as previously disclosed in its press release dated November 18, 2020, that its wholly owned subsidiary, Groupe Technologique KDA Inc. (“Tech KDA”) has entered into an asset purchase and rights assignment agreement (the “Asset […]